Skip to content

The effect and mechanism of effective components of Miyaning in treating kidney stone

The effect and mechanism of effective components of Miyaning in treating kidney stone

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104206
Enrollment
Unknown
Registered
2025-06-12
Start date
2025-06-18
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney stone

Interventions

Blank control group:None
Biyanning group:Miyanning

Sponsors

Yuebei People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age range: 18-65 years old; 2.CT diagnosis confirmed that the diameter of kidney stones is less than 10mm; 3.Patients who voluntarily participate in this study, cooperate throughout the process, and actively respond to follow-up visits.

Exclusion criteria

Exclusion criteria: 1.People with serious cardiovascular, cerebrovascular, liver and kidney diseases and diabetes; 2.Women in the preconception, pregnancy, or lactation period; 3.Individuals currently taking other anti stone medications; 4.Suffering from urinary tract stones, with serious complications, severe hydronephrosis, infections, etc; 5.Refuse to take traditional Chinese medicine or have a history of allergies to the Chinese medicine used in this study.

Design outcomes

Primary

MeasureTime frame
Total effective rate of therapeutic effect;

Countries

China

Contacts

Public ContactYuefu Han

Yuebei People’s Hospital

hyf2540@126.com+86 751 6913329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026